Literature DB >> 16367690

Culturally competent assessment practice in the United States.

R H Dana1.   

Abstract

Assessment practice with multicultural populations in the United States requires cultural competence. Culturally competent assessment includes culture-specific styles of service delivery, use of the client's first language, and an evaluation of the client as a cultural being prior to test administration using cultural orientation categories. This information is essential for understanding health/illness beliefs, to indicate the possible presence of culture-specific symptoms, and to select standard or culture-specific tests. Assessment ethics recognize the desirability of alteration or modification of standard tests by translation and development of new norms. Cross-cultural construct validity, response sets, and cultural variables are also research priorities. Culture-specific tests should be constructed and validated for some clients as determined by cultural orientation status. Feedback of test findings to clients and significant others should be consistent with cultural expectations. Professional and societal benefits of cultural competence in assessment are suggested.

Year:  1996        PMID: 16367690     DOI: 10.1207/s15327752jpa6603_2

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  2 in total

Review 1.  Increasing culturally competent neuropsychological services for ethnic minority populations: a call to action.

Authors:  Monica Rivera Mindt; Desiree Byrd; Pedro Saez; Jennifer Manly
Journal:  Clin Neuropsychol       Date:  2010-04       Impact factor: 3.535

2.  Using the NIH Toolbox in special populations: considerations for assessment of pediatric, geriatric, culturally diverse, non-English-speaking, and disabled individuals.

Authors:  David Victorson; Jennifer Manly; Kathleen Wallner-Allen; Nathan Fox; Christy Purnell; Hugh Hendrie; Richard Havlik; Mark Harniss; Susan Magasi; Helena Correia; Richard Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.